March 11, 2020 / 9:11 PM / 21 days ago

BRIEF-Conatus Pharmaceuticals Reports 2019 Financial Results And Strategic Process Update

March 11 (Reuters) - Conatus Pharmaceuticals Inc:

* CONATUS PHARMACEUTICALS REPORTS 2019 FINANCIAL RESULTS AND STRATEGIC PROCESS UPDATE

* QTRLY LOSS PER SHARE $0.08

* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $20.7 MILLION AT DECEMBER 31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below